A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn’s Disease
Description
The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn’s disease.
Step 1: Add a recruitment campaign (optional)
Our expert team has 10+ years running successful recruitment campaigns for clinical research sites
Your plan includes posting your clinical trials on our recruitment portal and mobile apps. Boost your trials with targeted advertising campaigns to reach more participants, faster.
We handle everything: audience targeting, creative development, geo targeting to your site locations, and ongoing optimizations. Qualified participant inquiries flow directly into your dashboard. Inquiries typically begin within a few days and continue throughout the campaign.